Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock

$28.61

1.14% yesterday

NYSE, Jun 13, 10:10 pm CET

ISIN

US3580291066

Symbol

FMS

Reports

Quarter | Annual

Index

CDAX, NYSE Composite

Sector

Health

Industry

Health service provider

Overview Dividends Analysts Charts News Strategies

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock price

$28.61

-13.42 31.93% 5Y

NYSE, Closing price Fri, Jun 13 2025

-0.33 1.14%

ISIN

US3580291066

Symbol

FMS

Reports

Quarter | Annual

Index

CDAX, NYSE Composite

Sector

Health

Industry

Health service provider

Key metrics

Market capitalization	$16.90b
Enterprise Value	$27.68b
P/E (TTM) P/E ratio	11.77
EV/FCF (TTM) EV/FCF	14.26
EV/Sales (TTM) EV/Sales	1.23
P/S ratio (TTM) P/S ratio	0.75
P/B ratio (TTM) P/B ratio	0.51
Dividend yield	2.85%
Last dividend (FY25)	$0.81
Revenue growth (TTM) Revenue growth	0.10%
Revenue (TTM) Revenue	$22.51b
EBIT (operating result TTM) EBIT	$1.54b
Free Cash Flow (TTM) Free Cash Flow	$1.94b
Cash position	$1.72b
EPS (TTM) EPS	$2.43
P/E forward	15.76
P/S forward	0.76
EV/Sales forward	1.24
Short interest	0.20%

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Get Started for Free Today

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock Analysis

Unlock Scores for Free

??

21 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

7x Buy

33%

9x Hold

43%

5x Sell

24%

More details on Analyst Estimates Including Price Targets

21 Analysts have issued a Fresenius Medical Care AG & Co. KGaA Sponsored ADR forecast:

Buy

33%

Hold

43%

Sell

24%

Analyst Estimates with Stock Price Targets

Financial data from Fresenius Medical Care AG & Co. KGaA Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	22,513 22,513	0% 0% 100%
- Direct Costs	17,008 17,008	1% 1% 76%
Gross Profit	5,506 5,506	4% 4% 24%
- Selling and Administrative Expenses	3,601 3,601	2% 2% 16%
- Research and Development Expense	207 207	19% 19% 1%
EBITDA	3,413 3,413	5% 5% 15%
- Depreciation and Amortization	1,876 1,876	11% 11% 8%
EBIT (Operating Income) EBIT	1,537 1,537	4% 4% 7%
Net Profit	714 714	28% 28% 3%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Fresenius Medical Care AG & Co. KGaA Sponsored ADR Stock News

Neutral

PRNewsWire

●

10 days ago

Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.

Updated 5008X CAREsystem with Additional Features Receives FDA 510(k) Clearance Company announces first wave of Fresenius Kidney Care clinics in the U.S. to begin offering high-volume hemodiafiltration therapy to dialysis patients Introducing the 5008X CAREsystem and hemodiafiltration kidney replacement therapy is a key pillar of the company's growth strategy BAD HOMBURG, Germany , June 4, 202...

Neutral

PRNewsWire

●

15 days ago

Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025

Key abstract presentations showcase significant advancements in clinical care, artificial intelligence, and fluid management, demonstrating Fresenius Medical Care's commitment to improving patient outcomes. Top Abstract recognition for "Prevalence and Patterns of Intradialytic Arterial Oxygen Saturation Instability: Observations in a Large U.S. Hemodialysis Cohort," presented in the "Dialysis" ...

Neutral

PRNewsWire

●

23 days ago

Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History

Shareholders approved the proposed dividend of 1.44 Euro per share, representing a 21 percent increase year-over-year and marking the highest dividend in the company's history Excellent progress in the company's transformation and turnaround plans continues to strengthen the foundation for sustainable, profitable growth In 2024, organic revenue growth1 was 4 percent, and operating income increa...

More Fresenius Medical Care AG & Co. KGaA Sponsored ADR News

Company Profile

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Head office	Germany
CEO	Helen Giza
Employees	111,513
Founded	1996
Website	www.freseniusmedicalcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now